Atlas Trials

BRAF V600E-mutant Metastatic Colorectal Cancer

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF V600E-mutant Metastatic Colorectal Cancer

RecordFirmDate
A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer (NCT07007689)Sun Yat-sen University2025-07-01
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer (NCT03693170)Pierre Fabre Medicament2019-01-17
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer (NCT02928224)Pfizer2016-10-13

Track BRAF V600E-mutant Metastatic Colorectal Cancer automatically

Every clearance here is in the API, with alerts when new ones post.